{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:10:59Z","timestamp":1792797059646,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202401148ZYTS"],"award-info":[{"award-number":["YDZJ202401148ZYTS"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS155"],"award-info":[{"award-number":["YDZJ202201ZYTS155"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25981-7","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:45:16Z","timestamp":1763387116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chrysanthemum morifolium extract improves metabolic dysfunction-associated fatty liver disease by regulating lipid metabolism"],"prefix":"10.1038","volume":"15","author":[{"given":"Wenjing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhua","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"25981_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12072-024-10774-3","volume":"19","author":"M Eslam","year":"2025","unstructured":"Eslam, M. et al. The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease. Hepatol. Int. 19, 261\u2013301 (2025).","journal-title":"Hepatol. Int."},{"key":"25981_CR2","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.3748\/wjg.v25.i34.5105","volume":"25","author":"J-M Yang","year":"2019","unstructured":"Yang, J-M. et al. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World J. Gastroenterol. 25, 5105\u20135119 (2019).","journal-title":"World J. Gastroenterol."},{"key":"25981_CR3","doi-asserted-by":"publisher","first-page":"6750","DOI":"10.1080\/21655979.2022.2045837","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Quantitative proteomics analysis based on tandem mass Tag labeling coupled with labeling coupled with liquid chromatography-tandem mass spectrometry discovers the effect of Silibinin on non-alcoholic fatty liver disease in mice. Bioengineered 13, 6750\u20136766 (2022).","journal-title":"Bioengineered"},{"key":"25981_CR4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40519-021-01182-9","volume":"27","author":"S Bettini","year":"2022","unstructured":"Bettini, S. et al. Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study. Eat. Weight Disord. 27, 335\u2013343 (2022).","journal-title":"Eat. Weight Disord"},{"key":"25981_CR5","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/bph.14938","volume":"177","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice. Br. J. Pharmacol. 177, 1806\u20131821 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"25981_CR6","unstructured":"Chang, B., Baosen, L. I. & Zou, Z. An excerpt of EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Linchuang Gandanbing Zazhi 2016, 32 :1450\u20131454"},{"key":"25981_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3945\/jn.114.197533","volume":"144","author":"D Yu","year":"2014","unstructured":"Yu, D. et al. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. J. Nutr. 144, 2034\u20132040 (2014).","journal-title":"J. Nutr."},{"key":"25981_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/md20080470","volume":"20","author":"GP Chaves Filho","year":"2022","unstructured":"Chaves Filho, G. P., Batista, L. A. N. C., de Medeiros, S. R. B., Rocha, H. A. O. & Moreira, S. M. G. Sulfated glucan from the green seaweed Caulerpa sertularioides inhibits adipogenesis through suppression of adipogenic and lipogenic key factors. Mar. Drugs. 20, 470 (2022).","journal-title":"Mar. Drugs"},{"key":"25981_CR9","doi-asserted-by":"publisher","first-page":"884237","DOI":"10.3389\/fcimb.2022.884237","volume":"12","author":"MT Nascimento","year":"2022","unstructured":"Nascimento, M. T. et al. Pioglitazone, a peroxisome Proliferator-Activated Receptor-\u03b3 Agonist, downregulates the inflammatory response in cutaneous leishmaniasis patients without interfering in Leishmania Braziliensis killing by monocytes. Front. Cell. Infect. Microbiol. 12, 884237 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"25981_CR10","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","volume":"137","author":"D Li","year":"2009","unstructured":"Li, D., Yeung, S-C-J., Hassan, M. M., Konopleva, M. & Abbruzzese, J. L. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137, 482\u2013488 (2009).","journal-title":"Gastroenterology"},{"key":"25981_CR11","doi-asserted-by":"publisher","first-page":"538","DOI":"10.5604\/01.3001.0010.0284","volume":"16","author":"A Said","year":"2017","unstructured":"Said, A. & Akhter, A. Meta-Analysis of randomized controlled trials of Pharmacologic agents in Non-alcoholic steatohepatitis. Ann. Hepatol. 16, 538\u2013547 (2017).","journal-title":"Ann. Hepatol."},{"key":"25981_CR12","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s10620-016-4153-y","volume":"61","author":"WN Hannah","year":"2016","unstructured":"Hannah, W. N. & Harrison, S. A. Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease. Dig. Dis. Sci. 61, 1365\u20131374 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"25981_CR13","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1080\/21655979.2022.2037374","volume":"13","author":"G Jiang","year":"2022","unstructured":"Jiang, G. et al. Hepatoprotective mechanism of Silybum Marianum on nonalcoholic fatty liver disease based on network Pharmacology and experimental verification. Bioengineered 13, 5216\u20135235 (2022).","journal-title":"Bioengineered"},{"key":"25981_CR14","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/gutjnl-2021-324170","volume":"71","author":"N Liu","year":"2022","unstructured":"Liu, N., Wang, X., Steer, C. J. & Song, G. MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells. Gut 71, 1642\u20131655 (2022).","journal-title":"Gut"},{"key":"25981_CR15","first-page":"4282","volume":"130","author":"X Pan","year":"2020","unstructured":"Pan, X., Queiroz, J. & Hussain, M. M. Nonalcoholic fatty liver disease in CLOCK mutant mice. J. Clin. Invest. 130, 4282\u20134300 (2020).","journal-title":"J. Clin. Invest."},{"key":"25981_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41419-022-04812-x","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. Cell. Death Dis. 13, 359 (2022).","journal-title":"Cell. Death Dis."},{"key":"25981_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/nu10060735","volume":"10","author":"AR Im","year":"2018","unstructured":"Im, A. R., Yang, W. K., Park, Y. C., Kim, S. H. & Chae, S. Hepatoprotective effects of insect extracts in an animal model of nonalcoholic fatty liver disease. Nutrients 10, 735 (2018).","journal-title":"Nutrients"},{"key":"25981_CR18","doi-asserted-by":"publisher","first-page":"591608","DOI":"10.3389\/fphar.2021.591608","volume":"12","author":"X Xie","year":"2021","unstructured":"Xie, X. et al. Liangxue Jiedu formula improves psoriasis and dyslipidemia comorbidity via PI3K\/Akt\/mTOR pathway. Front. Pharmacol. 12, 591608 (2021).","journal-title":"Front. Pharmacol."},{"key":"25981_CR19","first-page":"221","volume":"7","author":"A Berlanga","year":"2014","unstructured":"Berlanga, A., Guiu-Jurado, E., Porras, J. A. & Auguet, T. Molecular pathways in non-alcoholic fatty liver disease. Clin. Exp. Gastroenterol. 7, 221\u2013239 (2014).","journal-title":"Clin. Exp. Gastroenterol."},{"key":"25981_CR20","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3390\/ijms19082291","volume":"19","author":"Z Wu","year":"2018","unstructured":"Wu, Z., Yang, F., Jiang, S., Sun, X. & Xu, J. Induction of liver steatosis in BAP31-Deficient mice burdened with Tunicamycin-Induced Endoplasmic reticulum stress. Int. J. Mol. Sci. 19, 2291 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"25981_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jcmgh.2019.04.007","volume":"8","author":"WP Esler","year":"2019","unstructured":"Esler, W. P. & Bence, K. K. Metabolic targets in nonalcoholic fatty liver disease. Cell. Mol. Gastroenterol. Hepatol. 8, 247\u2013267 (2019).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"25981_CR22","doi-asserted-by":"crossref","unstructured":"Strand, E. et al. Serum acylcarnitines and risk of cardiovascular death and acute myocardial infarction in patients with stable angina pectoris. J. Am. Heart Assoc. ;6. (2017).","DOI":"10.1161\/JAHA.116.003620"},{"key":"25981_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41401-019-0311-z","volume":"41","author":"X-L Zhang","year":"2020","unstructured":"Zhang, X-L. et al. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathway. Acta Pharmacol. Sin. 41, 383\u2013393 (2020).","journal-title":"Acta Pharmacol. Sin"},{"key":"25981_CR24","doi-asserted-by":"crossref","unstructured":"Lee, Y. H. et al. .et al. Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA. Elife ;10:. (2021).","DOI":"10.7554\/eLife.70472"},{"key":"25981_CR25","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.2337\/db16-1519","volume":"66","author":"MP Franklin","year":"2017","unstructured":"Franklin, M. P., Sathyanarayan, A. & Mashek, D. G. Acyl-CoA thioesterase 1 (ACOT1) regulates PPAR\u03b1 to couple fatty acid flux with oxidative capacity during fasting. Diabetes 66, 2112\u20132123 (2017).","journal-title":"Diabetes"},{"key":"25981_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87\u201391 (1993).","journal-title":"Science"},{"key":"25981_CR27","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI117899","volume":"95","author":"PA Kern","year":"1995","unstructured":"Kern, P. A. et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95, 2111\u20132119 (1995).","journal-title":"J. Clin. Invest."},{"key":"25981_CR28","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.15252\/msb.209495","volume":"16","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease. Mol. Syst. Biol. 16, 9495 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"25981_CR29","first-page":"290","volume":"34","author":"Z Xie Zhanfang","year":"2015","unstructured":"Xie Zhanfang, Z. et al. Progress of research on chemical composition and Pharmacological activity of chrysanthemum. J. Henan Univ. (Medical Edition). 34, 290\u2013300 (2015).","journal-title":"J. Henan Univ. (Medical Edition)"},{"key":"25981_CR30","doi-asserted-by":"publisher","first-page":"e39890","DOI":"10.1016\/j.heliyon.2024.e39890","volume":"10","author":"Y Lei","year":"2024","unstructured":"Lei, Y. et al. Lactucin ameliorates FFA-induced steatosis in HepG2 cells by modulating mitochondrial homeostasis through the SIRT1\/PGC-1\u03b1 signaling axis. Heliyon 10, e39890 (2024).","journal-title":"Heliyon"},{"key":"25981_CR31","doi-asserted-by":"crossref","unstructured":"Xiao, Q. et al. Ginsenoside Rg1 Ameliorates Palmitic Acid-Induced Hepatic Steatosis and Inflammation in HepG2 Cells via the AMPK\/NF-\u03baB Pathway. Int J Endocrinol 7514802 (2019). (2019).","DOI":"10.1155\/2019\/7514802"},{"key":"25981_CR32","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.redox.2020.101600","volume":"36","author":"D Kong","year":"2020","unstructured":"Kong, D. et al. Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy. Redox Biol. 36, 101600 (2020).","journal-title":"Redox Biol."},{"key":"25981_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"25981_CR34","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCRESAHA.116.310498","volume":"120","author":"A Kuo","year":"2017","unstructured":"Kuo, A., Lee, M. Y. & Sessa, W. C. Lipid droplet biogenesis and function in the endothelium. Circ. Res. 120, 1289\u20131297 (2017).","journal-title":"Circ. Res."},{"key":"25981_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/biom12010057","volume":"12","author":"T Li","year":"2021","unstructured":"Li, T., Guo, W. & Zhou, Z. Adipose triglyceride lipase in hepatic physiology and pathophysiology. Biomolecules 12, 57 (2021).","journal-title":"Biomolecules"},{"key":"25981_CR36","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/hep.30583","volume":"69","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Kory, N., BasuRay, S., Cohen, J. C. & Hobbs, H. H. PNPLA3, CGI-58, and Inhibition of hepatic triglyceride hydrolysis in mice. Hepatology 69, 2427\u20132441 (2019).","journal-title":"Hepatology"},{"key":"25981_CR37","doi-asserted-by":"publisher","first-page":"104085","DOI":"10.1016\/j.isci.2022.104085","volume":"25","author":"G Zhang","year":"2022","unstructured":"Zhang, G. et al. The vesicular transporter STX11 governs ATGL-mediated hepatic lipolysis and lipophagy. iScience 25, 104085 (2022).","journal-title":"iScience"},{"key":"25981_CR38","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/hep.24645","volume":"54","author":"C Wu","year":"2011","unstructured":"Wu, C. et al. Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking. Hepatology 54, 1966\u20131974 (2011).","journal-title":"Hepatology"},{"key":"25981_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/md20040225","volume":"20","author":"J Ye","year":"2022","unstructured":"Ye, J. et al. Fucoxanthin attenuates free fatty Acid-Induced nonalcoholic fatty liver disease by regulating lipid Metabolism\/Oxidative Stress\/Inflammation via the AMPK\/Nrf2\/TLR4 signaling pathway. Mar. Drugs. 20, 225 (2022).","journal-title":"Mar. Drugs"},{"key":"25981_CR40","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.3390\/foods10123085","volume":"10","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Lipid-Lowering effects of Inonotus obliquus polysaccharide in vivo and in vitro. Foods 10, 3085 (2021).","journal-title":"Foods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25981-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25981-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:45:22Z","timestamp":1763387122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25981-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25981"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25981-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40069"}}